Page last updated: 2024-08-24

tiagabine and Benign Psychomotor Epilepsy, Childhood

tiagabine has been researched along with Benign Psychomotor Epilepsy, Childhood in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Celani, MVB; Dos Santos, WF; Gobbo-Neto, L; Godoy, LD; Liberato, JL; Lopes, NP1
Morimoto, K; Sato, H; Suwaki, H; Watanabe, T; Yamamoto, Y1
Breustedt, J; Draguhn, A; Engel, D; Frahm, C; Heinemann, U; Numberger, M; Pfeiffer, M; Piechotta, A; Sabau, A1
Grabowska-Grzyb, A; WolaƄczyk, T1
Genton, P; Guerrini, R; Perucca, E1
Brouns, R; Van Paesschen, W1

Reviews

1 review(s) available for tiagabine and Benign Psychomotor Epilepsy, Childhood

ArticleYear
Tiagabine in clinical practice.
    Epilepsia, 2001, Volume: 42 Suppl 3

    Topics: Anticonvulsants; Confusion; Drug Administration Schedule; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Humans; Nipecotic Acids; Practice Guidelines as Topic; Tiagabine; Treatment Outcome

2001

Other Studies

5 other study(ies) available for tiagabine and Benign Psychomotor Epilepsy, Childhood

ArticleYear
Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
    Toxins, 2017, 08-25, Volume: 9, Issue:9

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Male; Neurons; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Pilocarpine; Rats, Wistar; Spider Venoms; Tiagabine; Urea

2017
Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Epilepsia, 1997, Volume: 38, Issue:9

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Dose-Response Relationship, Drug; Electric Stimulation; Electroencephalography; Epilepsy, Temporal Lobe; gamma-Aminobutyric Acid; Kindling, Neurologic; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Picrotoxin; Rats; Rats, Sprague-Dawley; Tiagabine; Valproic Acid

1997
Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    European journal of pharmacology, 1999, Nov-03, Volume: 383, Issue:3

    Topics: Action Potentials; Age Factors; Animals; Animals, Newborn; Anticonvulsants; Carrier Proteins; Entorhinal Cortex; Epilepsy, Temporal Lobe; Female; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Hippocampus; Male; Membrane Proteins; Membrane Transport Proteins; Nipecotic Acids; Organic Anion Transporters; Rats; Rats, Wistar; Tiagabine

1999
Transient dystonias in three patients treated with tiagabine.
    Epilepsia, 2001, Volume: 42, Issue:7

    Topics: Acute Disease; Adult; Anticonvulsants; Basal Ganglia Diseases; Carbamazepine; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Epilepsy; Epilepsy, Frontal Lobe; Epilepsy, Temporal Lobe; Female; Humans; Male; Nipecotic Acids; Tiagabine

2001
Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
    Acta neurologica Belgica, 2002, Volume: 102, Issue:1

    Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Humans; Lorazepam; Male; Meningoencephalitis; Nipecotic Acids; Status Epilepticus; Tiagabine; Treatment Outcome

2002